2020
DOI: 10.1016/j.ymben.2020.01.003
|View full text |Cite
|
Sign up to set email alerts
|

In vivo directed enzyme evolution in nanoliter reactors with antimetabolite selection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(14 citation statements)
references
References 48 publications
0
14
0
Order By: Relevance
“…Moving away from model enrichments and display of platform capabilities, many research groups are now working on improving enzymes with industrial or medical relevance. [ 65 , 74 , 76 , 150 , 152 , 153 ] Besides the evolution of natural enzymes, the toolkit of directed evolution is expanding to artificial enzymes to introduce non‐natural reactivities urgently needed in the pharmaceutical industry, [152] de novo designed enzymes to understand and reengineer enzyme active sites, and, more recently, machine‐learning‐assisted directed evolution. [154] Furthermore, as fluorogenic substrates cannot always be synthesized, novel strategies for fast, but non‐fluorescence‐based detection will be critical for future developments.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moving away from model enrichments and display of platform capabilities, many research groups are now working on improving enzymes with industrial or medical relevance. [ 65 , 74 , 76 , 150 , 152 , 153 ] Besides the evolution of natural enzymes, the toolkit of directed evolution is expanding to artificial enzymes to introduce non‐natural reactivities urgently needed in the pharmaceutical industry, [152] de novo designed enzymes to understand and reengineer enzyme active sites, and, more recently, machine‐learning‐assisted directed evolution. [154] Furthermore, as fluorogenic substrates cannot always be synthesized, novel strategies for fast, but non‐fluorescence‐based detection will be critical for future developments.…”
Section: Discussionmentioning
confidence: 99%
“…Starting from a library with 1.2×10 7 variants, they observed an up to 2.7‐fold k cat / K M improvement over wild type after three rounds of directed evolution. [65] …”
Section: Single Emulsionsmentioning
confidence: 99%
“…Moving away from model enrichments and display of platform capabilities,many research groups are now working on improving enzymes with industrial or medical relevance. [65,74,76,150,152,153] Besides the evolution of natural enzymes,t he toolkit of directed evolution is expanding to artificial enzymes to introduce non-natural reactivities urgently needed in the pharmaceutical industry, [152] de novo designed enzymes to understand and reengineer enzyme active sites,a nd, more recently,m achine-learning-assisted directed evolution. [154] Furthermore,asfluorogenic substrates cannot always be synthesized, novel strategies for fast, but non-fluorescence-based detection will be critical for future developments.…”
Section: Discussionmentioning
confidence: 99%
“…Starting from al ibrary with 1.2 10 7 variants,t hey observed an up to 2.7-fold k cat /K M improvement over wild type after three rounds of directed evolution. [65] 2.2. Technology Advances II:Microfluidics-Based Droplet Formation and Reduction of Cross Talk between Droplets…”
Section: Methodsmentioning
confidence: 99%
“…The group of Sven Panke (ETHZ Basel) recently reported a method for in vivo directed enzyme evolution in nanoliter reactions with anti-metabolite selection [15]. The researchers were interested in producing sulphostin, a dipeptidyl peptidase IV inhibitor and potential type 2 diabetes drug from racemic ornithine.…”
Section: Screeningmentioning
confidence: 99%